Back to Search
Start Over
Oral Abstract: ABCL-101 Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
- Source :
- Clinical Lymphoma Myeloma and Leukemia. 22:S117
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 21522650
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Clinical Lymphoma Myeloma and Leukemia
- Accession number :
- edsair.doi...........4a026904afd79a9f1d44f929f1be0228
- Full Text :
- https://doi.org/10.1016/s2152-2650(22)00700-5